Zhi Qi

2.1k total citations
65 papers, 1.6k citations indexed

About

Zhi Qi is a scholar working on Molecular Biology, Virology and Immunology. According to data from OpenAlex, Zhi Qi has authored 65 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Virology and 15 papers in Immunology. Recurrent topics in Zhi Qi's work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (11 papers) and Inflammasome and immune disorders (7 papers). Zhi Qi is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (11 papers) and Inflammasome and immune disorders (7 papers). Zhi Qi collaborates with scholars based in China, United States and Japan. Zhi Qi's co-authors include Shibo Jiang, Hong Lü, Chungen Pan, Yuxian He, Jingjing Li, Shuwen Liu, Yanna Shen, Qiuyun Dai, Robyn Gershon and Liang Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Zhi Qi

63 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhi Qi China 25 578 518 480 239 155 65 1.6k
Emmanuel Fenouillet France 25 790 1.4× 725 1.4× 364 0.8× 396 1.7× 271 1.7× 84 2.1k
Yuan Lu China 20 622 1.1× 360 0.7× 274 0.6× 164 0.7× 138 0.9× 85 1.3k
Robin Hull United Kingdom 14 328 0.6× 251 0.5× 236 0.5× 314 1.3× 228 1.5× 20 1.6k
Elizabeth Röth Hungary 17 223 0.4× 720 1.4× 737 1.5× 84 0.4× 236 1.5× 52 1.5k
Carolyn Napier United Kingdom 12 433 0.7× 653 1.3× 485 1.0× 239 1.0× 167 1.1× 19 1.3k
Shan Lü China 21 974 1.7× 280 0.5× 116 0.2× 341 1.4× 261 1.7× 87 1.9k
Ana M. Sánchez United States 34 627 1.1× 207 0.4× 318 0.7× 796 3.3× 298 1.9× 84 3.2k
Stephen S. Hwang United States 17 314 0.5× 812 1.6× 531 1.1× 376 1.6× 174 1.1× 38 1.8k
Ella H. Sklan Israel 28 994 1.7× 114 0.2× 354 0.7× 271 1.1× 429 2.8× 61 2.4k

Countries citing papers authored by Zhi Qi

Since Specialization
Citations

This map shows the geographic impact of Zhi Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Qi more than expected).

Fields of papers citing papers by Zhi Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Qi. The network helps show where Zhi Qi may publish in the future.

Co-authorship network of co-authors of Zhi Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi Qi. A scholar is included among the top collaborators of Zhi Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi Qi. Zhi Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Lifeng, Ruopeng Sun, Hanmo Zhang, et al.. (2025). Exploring the protective mechanisms of syringaresinol against myocardial infarction by experimental validation and network pharmacology. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(4). 167728–167728. 1 indexed citations
2.
Li, Guangru, Ruiqing Liu, Ruopeng Sun, et al.. (2025). Inhibition of CAV1 attenuates diabetic cardiomyopathy through reducing ferroptosis via activating NRF2/GCLC signaling pathway. Theranostics. 15(11). 4989–5006. 2 indexed citations
3.
4.
5.
Liu, Zhuang, Runze Li, Shiqi Zhang, et al.. (2024). E3 ubiquitin ligase DTX2 fosters ferroptosis resistance via suppressing NCOA4-mediated ferritinophagy in non-small cell lung cancer. Drug Resistance Updates. 77. 101154–101154. 19 indexed citations
6.
Liu, Chang, Jia Liu, Shiqi Zhang, et al.. (2024). YOD1 protects against MRSA sepsis-induced DIC through Lys33-linked deubiquitination of NLRP3. Cell Death and Disease. 15(5). 360–360. 7 indexed citations
8.
Zou, Quan, Jia Liu, Junwei Zhang, et al.. (2022). Melanin nanoparticles alleviate sepsis-induced myocardial injury by suppressing ferroptosis and inflammation. Bioactive Materials. 24. 313–321. 63 indexed citations
9.
Liu, Yuansheng, Qian Zhang, Lei Yang, et al.. (2022). Metformin Attenuates Cardiac Hypertrophy Via the HIF-1α/PPAR-γ Signaling Pathway in High-Fat Diet Rats. Frontiers in Pharmacology. 13. 919202–919202. 9 indexed citations
10.
Feng, Lifeng, Guangru Li, Xiaolong Zhu, et al.. (2021). Exercise Training Protects Against Heart Failure Via Expansion of Myeloid-Derived Suppressor Cells Through Regulating IL-10/STAT3/S100A9 Pathway. Circulation Heart Failure. 15(3). e008550–e008550. 34 indexed citations
11.
Zhang, Qian, et al.. (2021). Mst1/2-ALK promotes NLRP3 inflammasome activation and cell apoptosis during Listeria monocytogenes infection. The Journal of Microbiology. 59(7). 681–692. 10 indexed citations
12.
Li, Guangru, Lei Yang, Lei Yang, et al.. (2020). Syringaresinol Protects against Type 1 Diabetic Cardiomyopathy by Alleviating Inflammation Responses, Cardiac Fibrosis, and Oxidative Stress. Molecular Nutrition & Food Research. 64(18). e2000231–e2000231. 50 indexed citations
13.
Qi, Zhi, Jacqueline Merrill, & Robyn Gershon. (2017). Mass-Fatality Incident Preparedness Among Faith-Based Organizations. Prehospital and Disaster Medicine. 32(6). 596–603. 5 indexed citations
14.
Liu, Fei, Wencong Tian, Qiong Zhang, et al.. (2014). Optimal method for short-term or long-term islet preservation: comparison of islet culture, cold preservation and cryopreservation. Journal of Artificial Organs. 17(4). 337–343. 21 indexed citations
15.
Lu, Lu, Yanxia Chen, Fei Yu, et al.. (2013). F(ab′)2 fragment of a gp41 NHR-trimer-induced IgM monoclonal antibody neutralizes HIV-1 infection and blocks viral fusion by targeting the conserved gp41 pocket. Microbes and Infection. 15(13). 887–894. 3 indexed citations
16.
Li, Lin, Lili He, Suiyi Tan, et al.. (2010). 3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin Exhibits Potent and Broad Anti-HIV-1 Activity: a Potential Microbicide for Preventing Sexual Transmission of HIV-1. Antimicrobial Agents and Chemotherapy. 54(5). 1700–1711. 35 indexed citations
17.
Wang, Hongtao, Zhi Qi, Hong Lü, et al.. (2009). ADS-J1 Inhibits Human Immunodeficiency Virus Type 1 Entry by Interacting with the gp41 Pocket Region and Blocking Fusion-Active gp41 Core Formation. Antimicrobial Agents and Chemotherapy. 53(12). 4987–4998. 52 indexed citations
18.
Pan, Chungen, Hong Lü, Zhi Qi, & Shibo Jiang. (2009). Synergistic efficacy of combination of enfuvirtide and sifuvirtide, the first- and next-generation HIV-fusion inhibitors. AIDS. 23(5). 639–641. 32 indexed citations
19.
He, Yuxian, Jingjing Li, Zhi Qi, et al.. (2008). Identification of a Critical Motif for the Human Immunodeficiency Virus Type 1 (HIV-1) gp41 Core Structure: Implications for Designing Novel Anti-HIV Fusion Inhibitors. Journal of Virology. 82(13). 6349–6358. 76 indexed citations
20.
Chen, Xuesong, Shaopeng Chi, Mingna Liu, et al.. (2005). Inhibitory effect of ganglioside GD1b on K+ current in hippocampal neurons and its involvement in apoptosis suppression. Journal of Lipid Research. 46(12). 2580–2585. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026